Subsequently, anti-NXP2 antibodies have been also detected in approximately 30% of patients with DM and 8% with PM in a cohort of 58 adult Italian patients (109), but in only 1.6% of 507 adult Japanese patients (110). Here, MORC3 is linked to dermatomyositis.